KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Return on Assets (2016 - 2025)

Historic Return on Assets for Xenon Pharmaceuticals (XENE) over the last 12 years, with Q3 2025 value amounting to 0.5%.

  • Xenon Pharmaceuticals' Return on Assets fell 2500.0% to 0.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5%, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of 0.28% for FY2024, which is 700.0% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Return on Assets stood at 0.5% for Q3 2025, which was down 2500.0% from 0.41% recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Return on Assets ranged from a high of 0.13% in Q2 2022 and a low of 0.5% during Q3 2025
  • Over the past 5 years, Xenon Pharmaceuticals' median Return on Assets value was 0.22% (recorded in 2024), while the average stood at 0.24%.
  • In the last 5 years, Xenon Pharmaceuticals' Return on Assets surged by 1000bps in 2022 and then crashed by -2500bps in 2025.
  • Quarter analysis of 5 years shows Xenon Pharmaceuticals' Return on Assets stood at 0.19% in 2021, then increased by 13bps to 0.16% in 2022, then crashed by -36bps to 0.22% in 2023, then tumbled by -36bps to 0.3% in 2024, then tumbled by -64bps to 0.5% in 2025.
  • Its Return on Assets stands at 0.5% for Q3 2025, versus 0.41% for Q2 2025 and 0.34% for Q1 2025.